Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,031 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Specific CD4+ T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis.
Sun M, Phan JM, Kieswetter NS, Huang H, Yu KKQ, Smith MT, Liu YE, Wang C, Gupta S, Obermoser G, Maecker HT, Krishnan A, Suresh S, Gupta N, Rieck M, Acs P, Ghanizada M, Chiou SH, Khatri P, Boom WH, Hawn TR, Stein CM, Mayanja-Kizza H, Davis MM, Seshadri C. Sun M, et al. Among authors: krishnan a. Nat Immunol. 2024 Aug;25(8):1411-1421. doi: 10.1038/s41590-024-01897-8. Epub 2024 Jul 12. Nat Immunol. 2024. PMID: 38997431 Free PMC article.
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
Musvosvi M, Huang H, Wang C, Xia Q, Rozot V, Krishnan A, Acs P, Cheruku A, Obermoser G, Leslie A, Behar SM, Hanekom WA, Bilek N, Fisher M, Kaufmann SHE, Walzl G, Hatherill M, Davis MM, Scriba TJ; Adolescent Cohort Study team; GC6-74 Consortium. Musvosvi M, et al. Among authors: krishnan a. Nat Med. 2023 Jan;29(1):258-269. doi: 10.1038/s41591-022-02110-9. Epub 2023 Jan 5. Nat Med. 2023. PMID: 36604540 Free PMC article.
Author Correction: Specific CD4+ T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis.
Sun M, Phan JM, Kieswetter NS, Huang H, Yu KKQ, Smith MT, Liu YE, Wang C, Gupta S, Obermoser G, Maecker HT, Krishnan A, Suresh S, Gupta N, Rieck M, Acs P, Ghanizada M, Chiou SH, Khatri P, Boom WH, Hawn TR, Stein CM, Mayanja-Kizza H, Davis MM, Seshadri C. Sun M, et al. Among authors: krishnan a. Nat Immunol. 2024 Oct;25(10):1976. doi: 10.1038/s41590-024-01959-x. Nat Immunol. 2024. PMID: 39160374 Free PMC article. No abstract available.
Epidemiology of chronic and acute pancreatitis in India (EPICAP-India): protocol for a multicentre study.
Krishnan A, Pillai D, Amarchand R, Agarwal A, Ahuja V, Baloni V, Basu SS, Bhardwaj P, Choudhury B, Chowdhury SD, Dabar D, Das S, Deshmukh P, Devadas K, Dhali GK, Gunjan D, Gupta A, Jain S, Kedia S, Kumar R, Kumar S, Makharia GK, Monga N, Rungta S, Saraya A, Sarkar R, Shalimar, Sharma B, Singh S, Sujatha C, Wadhwa N, Garg PK. Krishnan A, et al. BMJ Open Gastroenterol. 2024 Dec 18;11(1):e001562. doi: 10.1136/bmjgast-2024-001562. BMJ Open Gastroenterol. 2024. PMID: 39694625 Free PMC article.
Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid® (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study.
Dongre SA, Kulkarni GA, Mishra A, Deshmane RB, Sonar N, Yashi K, Thapa D, Ghade N, Kadoo SM, Krishnan AR, Sonar SM. Dongre SA, et al. Among authors: krishnan ar. Res Pharm Sci. 2024 Oct 22;19(5):489-499. doi: 10.4103/RPS.RPS_188_23. eCollection 2024 Oct. Res Pharm Sci. 2024. PMID: 39691304 Free PMC article.
2,031 results